메뉴 건너뛰기




Volumn 42, Issue 5, 2011, Pages 405-411

VEGF-C as a Decision-making Biomarker for Selected Patients with Invasive Bladder Cancer Who Underwent Bladder-preserving Radical Surgery

Author keywords

Bladder transitional cell carcinoma; Lymphatic metastasis; Radical transurethral resection; Vascular endothelial growth factor C

Indexed keywords

VASCULOTROPIN C;

EID: 80052734281     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.07.006     Document Type: Article
Times cited : (10)

References (29)
  • 1
    • 79955629384 scopus 로고    scopus 로고
    • Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines
    • Stenzl A., Cowan N.C., De Santis M., et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011, 59:1009-1018.
    • (2011) Eur Urol , vol.59 , pp. 1009-1018
    • Stenzl, A.1    Cowan, N.C.2    De Santis, M.3
  • 2
    • 0017714612 scopus 로고    scopus 로고
    • Survival following transurethral resection of bladder carcinoma
    • Barnee R.W., Dick A.L., Hadley H.L., et al. Survival following transurethral resection of bladder carcinoma. Cancer Res 1997, 37:2895-2897.
    • (1997) Cancer Res , vol.37 , pp. 2895-2897
    • Barnee, R.W.1    Dick, A.L.2    Hadley, H.L.3
  • 3
    • 0023733498 scopus 로고
    • Comparison of transurethral resection to radical therapies for stage B bladder tumors
    • Henry K., Miller J., Mori M., et al. Comparison of transurethral resection to radical therapies for stage B bladder tumors. J Urol 1988, 140:964-967.
    • (1988) J Urol , vol.140 , pp. 964-967
    • Henry, K.1    Miller, J.2    Mori, M.3
  • 4
    • 0016751395 scopus 로고
    • Transurethral resection for the assessment and treatment of vesical neoplasms: a review of 840 consecutive cases
    • O'Flynn J.D., Smith J.D., Hanson J.S., et al. Transurethral resection for the assessment and treatment of vesical neoplasms: a review of 840 consecutive cases. Eur Urol 1975, 1:38-40.
    • (1975) Eur Urol , vol.1 , pp. 38-40
    • O'Flynn, J.D.1    Smith, J.D.2    Hanson, J.S.3
  • 5
    • 0023205227 scopus 로고
    • Conservative management of muscle-infiltrating bladder cancer: prospective experience
    • Herr H.W. Conservative management of muscle-infiltrating bladder cancer: prospective experience. J Urol 1987, 138:1162-1163.
    • (1987) J Urol , vol.138 , pp. 1162-1163
    • Herr, H.W.1
  • 6
    • 77955472338 scopus 로고    scopus 로고
    • Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer
    • Solsona E., Iborra I., Collado A., et al. Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer. J Urol 2010, 184:475-481.
    • (2010) J Urol , vol.184 , pp. 475-481
    • Solsona, E.1    Iborra, I.2    Collado, A.3
  • 7
    • 0035154545 scopus 로고    scopus 로고
    • Transurethral resection of muscle-invasive bladder cancer: 10-year outcome
    • Herr H.W. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 2001, 19:89-93.
    • (2001) J Clin Oncol , vol.19 , pp. 89-93
    • Herr, H.W.1
  • 8
    • 0030453355 scopus 로고    scopus 로고
    • VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
    • Kukk E., Lymboussaki A., Taira S., et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996, 122:3829-3837.
    • (1996) Development , vol.122 , pp. 3829-3837
    • Kukk, E.1    Lymboussaki, A.2    Taira, S.3
  • 9
    • 0037139421 scopus 로고    scopus 로고
    • Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas
    • Ueda M., Terai Y., Yamashita Y., et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer 2002, 98:335-343.
    • (2002) Int J Cancer , vol.98 , pp. 335-343
    • Ueda, M.1    Terai, Y.2    Yamashita, Y.3
  • 10
    • 33749578614 scopus 로고    scopus 로고
    • Vascular endothelial growth factor-C (VEGF-C) expression in bladder transitional cell cancer and its relationship to lymph node metastasis
    • Zu X.B., Tang Z.Y., Li Y., et al. Vascular endothelial growth factor-C (VEGF-C) expression in bladder transitional cell cancer and its relationship to lymph node metastasis. BJU Int 2006, 98:1090-1093.
    • (2006) BJU Int , vol.98 , pp. 1090-1093
    • Zu, X.B.1    Tang, Z.Y.2    Li, Y.3
  • 11
    • 0037099683 scopus 로고    scopus 로고
    • Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results
    • Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 2002, 20:3061-3071.
    • (2002) J Clin Oncol , vol.20 , pp. 3061-3071
    • Rodel, C.1    Grabenbauer, G.G.2    Kuhn, R.3
  • 12
    • 0031985484 scopus 로고    scopus 로고
    • Efficacy of radio-chemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer
    • Sauer R., Birkenhake S., Kuhn R., et al. Efficacy of radio-chemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 1998, 40:121-127.
    • (1998) Int J Radiat Oncol Biol Phys , vol.40 , pp. 121-127
    • Sauer, R.1    Birkenhake, S.2    Kuhn, R.3
  • 13
    • 0031986427 scopus 로고    scopus 로고
    • Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: long-term follow-up of a prospective study
    • Solsona E., Iborra I., Ricos J.V., et al. Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: long-term follow-up of a prospective study. J Urol 1998, 159:95-99.
    • (1998) J Urol , vol.159 , pp. 95-99
    • Solsona, E.1    Iborra, I.2    Ricos, J.V.3
  • 14
    • 0030030350 scopus 로고    scopus 로고
    • Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer
    • Tester W., Porter A., Heaney J., et al. Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer. J Clin Oncol 1996, 14:119-126.
    • (1996) J Clin Oncol , vol.14 , pp. 119-126
    • Tester, W.1    Porter, A.2    Heaney, J.3
  • 15
    • 0027452436 scopus 로고
    • Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: a prospective study
    • Housset M., Maulard C., Chretien Y.C., et al. Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: a prospective study. J Clin Oncol 1993, 11:2150-2157.
    • (1993) J Clin Oncol , vol.11 , pp. 2150-2157
    • Housset, M.1    Maulard, C.2    Chretien, Y.C.3
  • 16
    • 0035254218 scopus 로고    scopus 로고
    • Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients
    • Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
    • (2001) J Clin Oncol , vol.19 , pp. 666-675
    • Stein, J.P.1    Lieskovsky, G.2    Cote, R.3
  • 17
    • 0037446128 scopus 로고    scopus 로고
    • Overview of bladder cancer trials in the Radiation Therapy Oncology Group
    • Shipley W.U., Kaufman D.S., Tester W.J., et al. Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Cancer 2003, 97:2115-2119.
    • (2003) Cancer , vol.97 , pp. 2115-2119
    • Shipley, W.U.1    Kaufman, D.S.2    Tester, W.J.3
  • 18
    • 0031763392 scopus 로고    scopus 로고
    • Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03
    • Shipley W.U., Winter K.A., Kaufman D.S., et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 1998, 16:3576-3583.
    • (1998) J Clin Oncol , vol.16 , pp. 3576-3583
    • Shipley, W.U.1    Winter, K.A.2    Kaufman, D.S.3
  • 19
    • 26444442355 scopus 로고    scopus 로고
    • Organ-sparing treatment in muscle-invasive bladder cancer
    • Dunst J., Diestelhomt A., Kohn R., et al. Organ-sparing treatment in muscle-invasive bladder cancer. Strahlenther Onkol 2005, 181:632-637.
    • (2005) Strahlenther Onkol , vol.181 , pp. 632-637
    • Dunst, J.1    Diestelhomt, A.2    Kohn, R.3
  • 20
    • 0036290017 scopus 로고    scopus 로고
    • Selective bladder preservation by combined modal protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer
    • Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modal protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 2002, 60:62-67.
    • (2002) Urology , vol.60 , pp. 62-67
    • Shipley, W.U.1    Kaufman, D.S.2    Zehr, E.3
  • 21
    • 0025971521 scopus 로고
    • Carcinoma in situ associated with superficial bladder tumor
    • Solsona E., Iborra I., Rids J.V., et al. Carcinoma in situ associated with superficial bladder tumor. Eur Urol 1991, 19:93-96.
    • (1991) Eur Urol , vol.19 , pp. 93-96
    • Solsona, E.1    Iborra, I.2    Rids, J.V.3
  • 22
    • 0032847686 scopus 로고    scopus 로고
    • The impact of pelvic lymphadenectomy and radical cystectomy on outcome in lymph node positive bladder cancer
    • Vieweg J., Gschwend J., Herr H.W., et al. The impact of pelvic lymphadenectomy and radical cystectomy on outcome in lymph node positive bladder cancer. J Urol 1999, 161:72-76.
    • (1999) J Urol , vol.161 , pp. 72-76
    • Vieweg, J.1    Gschwend, J.2    Herr, H.W.3
  • 23
    • 0035515609 scopus 로고    scopus 로고
    • Molecular markers for diagnosis, staging and prognosis of bladder cancer
    • Williams S.G., Buscarini M., Stein J.P., et al. Molecular markers for diagnosis, staging and prognosis of bladder cancer. Oncology 2001, 15:1461-1484.
    • (2001) Oncology , vol.15 , pp. 1461-1484
    • Williams, S.G.1    Buscarini, M.2    Stein, J.P.3
  • 24
    • 0942298834 scopus 로고    scopus 로고
    • Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis
    • Koyama Y., Kaneko K., Akazawa K., et al. Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis. Clin Breast Cancer 2003, 4:354-360.
    • (2003) Clin Breast Cancer , vol.4 , pp. 354-360
    • Koyama, Y.1    Kaneko, K.2    Akazawa, K.3
  • 25
    • 1142275254 scopus 로고    scopus 로고
    • Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma
    • Onogawa S., Kitadai Y., Tanaka S., et al. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 2004, 95:32-39.
    • (2004) Cancer Sci , vol.95 , pp. 32-39
    • Onogawa, S.1    Kitadai, Y.2    Tanaka, S.3
  • 26
    • 0037267293 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma
    • Ishikawa M., Kitayama J., Kazama S., et al. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol 2003, 33:21-27.
    • (2003) Jpn J Clin Oncol , vol.33 , pp. 21-27
    • Ishikawa, M.1    Kitayama, J.2    Kazama, S.3
  • 27
    • 4143145525 scopus 로고    scopus 로고
    • Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers
    • Fujimoto J., Toyoki H., Sato E., et al. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. Br J Cancer 2004, 91:466-469.
    • (2004) Br J Cancer , vol.91 , pp. 466-469
    • Fujimoto, J.1    Toyoki, H.2    Sato, E.3
  • 28
    • 0042384574 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors
    • Hung C.J., Ginzinger D.G., Zarnegar R., et al. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab 2003, 88:3694-3699.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 3694-3699
    • Hung, C.J.1    Ginzinger, D.G.2    Zarnegar, R.3
  • 29
    • 0037439321 scopus 로고    scopus 로고
    • Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma
    • Arinaga M., Noguchi T., Takeno S., et al. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 2003, 97:457-464.
    • (2003) Cancer , vol.97 , pp. 457-464
    • Arinaga, M.1    Noguchi, T.2    Takeno, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.